Bedfont® Scientific Ltd secures a double win at the Kent Business Awards after being crowned ‘Medium Business of the Year 2024′ and ‘Best of Kent’.
About Bedfont® Scientific Ltd.
For over 48 years, Bedfont has specialised in designing and manufacturing breath analysis medical devices. Using innovative technology, Bedfont provides cutting-edge medical devices at affordable prices to improve accessibility and healthcare standards worldwide.
Our Values
Family Ethics
Innovative Thinking
Commitment to Patient Safety
Signed Up
Exceptional Services
Carbon Conscious
For more information on our values and a more thorough explanation into what these mean, see our values section on our careers page.
Our Mission
Our mission is to work with the Bedfont Family and healthcare professionals worldwide to provide cutting-edge breath analysis medical products to the highest standard, through technical innovation and professional business practice.
Our Vision
The Bedfont vision is a world where everyone has access to instant, non-invasive, simple breath testing to aid in medical diagnosis.
Our Values
Family Ethics
Innovative Thinking
Commitment to Patient Safety
Signed Up
Exceptional Services
Carbon Conscious
Who Are We?
Bedfont Scientific Ltd. creates leading-edge breath and gas analysis equipment. We are world leaders in breath analysis, with over 100 distributors worldwide.
Since 1976, we have specialised in the design and manufacture of exhaled breath and gas measuring instruments. Our products are used in a variety of industries including healthcare, pharmaceuticals, food manufacturing and diagnostics. Our expertise are reflected in the wide range of products that we offer – from portable to benchtop devices – which can be used to analyse the breath of patients.
For medical gas monitoring, our Medi-Gas Check medical pipeline testing range verifies not only the quantity but also quality of gas administered to patients.
Our breath analysers include carbon monoxide (CO) device, Smokerlyzer, used for smoking cessation.
The NObreath FeNO device provides accurate analysis of airway inflammation for the control of asthma, and the Gastrolyzer range aids in the detection of gastrointestinal disorders and food intolerances. Quick and non-invasive, breath analysis is the new blood test.
Over The Years
Bedfont Scientific Ltd, then called Bedfont Technical Instruments Ltd., was established in 1976 by Dr John Marron. It remained a one-man business until Trevor Smith joined as marketing director in March 1985. A chartered chemist with an extensive career in the chemical gas industry, Trevor channelled his ideas and innovation into the company that would, today, become the pioneer in breath analysis for medical applications.
Now, Jason Smith is the managing director, having succeeded his father, Trevor, who is now chairman, making Bedfont a 2nd generation family company. Jason’s aim for Bedfont is for its family values to be shown through its dedication to customers and the core business of breath analysis, whilst continuing to provide the best service and products to improve healthcare.
As well as breath monitoring, Bedfont has a strong background in the use of precision gases. It was a key OEM supplier of calibration gas mixtures, sold internationally to manufacturers of safety, environmental, emissions, and medical gas monitoring systems. In October 2004 this activity was sold to a major UK gas company, allowing more freedom to focus on the medical products within the business.
In January 2016, Bedfont created the subsidiary NOxBOX® Ltd after unprecedented success with the NOxBOX range. This was then sold to Praxair, Inc., a Fortune 250 company with sales of $11 billion in 2015, making it one of the largest gas companies worldwide, in March 2016. Praxair’s acquisition of NOxBOX Ltd included all of the NOxBOX range of critical care delivery and monitoring devices for iNO therapy.
Located in Harrietsham, Kent, termed the ‘Gateway to Europe’ for being close to major roads, railways and airports, Bedfont’s products are now available in over 70 countries and counting thanks to its unprecedented network of distributors. The name Bedfont is synonymous with quality and the company has achieved accreditation to BS EN ISO13485 and ISO9001.
Below is our timeline of all the exciting events over the years with Bedfont, have a flick through to see just how amazing we are!
2024
2023
August 2023 saw the opening of Bedfont’s Well-being garden, built in memory of 2 previous employees that sadly passed away in 2022. This space looks to offer a relaxation area during breaks.
2023
Bedfont® Scientific Ltd. became the manufacturer of a new PEMF device, CELLER8®, sold by NewMed Ltd. The CELLER8® delivers magnetic therapy using electromagnetic fields and is used to improve overall general wellness as part of a healthy lifestyle.
2023
Bedfont® welcomed its local MP, Helen Whately, to its offices in the summer of 2023. Helen explored the product range display, unveiling the evolution of their creations. These visits hold great significance, instilling pride in Bedfont® as they proudly exhibit their remarkable work.
2023
The NObreath® range celebrated 15 years of aiding in the management and diagnosis of asthma. In aid of this, a new logo was created.
2023
Bedfont® Scientific Ltd. work hard to be carbon conscious, sustainable and eco-friendly, and in February 2023 had solar panels installed. This is a huge investment for Bedfont®, and one they hope they will hugely benefit from.
2022
Bedfont’s NObreath® device for airway inflammation has been cleared for sale in the USA. The U.S. Food and Drug Administration (FDA) cleared the NObreath® FeNO device for use in monitoring airway inflammation.
2022
Bedfont® is recognised for its innovation for the 2nd year in a row at the Kent Invicta Chamber of Commerce (KICC) Awards in November 2022. Kent’s esteemed businesses gathered at Westernhanger Castle for the annual awards to celebrate the achievements of Kent companies.
2022
The SteriBreath Eco was launched in 2022. It has been made from a sustainable source and can now be recycled. Bedfont® also have a team of Eco Warriors who are there to encourage and promote Bedfont® as an Eco friendly company.
2021
The long-awaited Kent Invicta Chamber of Commerce (KICC) awards took place on Thursday 18th November, and named medical device manufacturer, Bedfont®, as Innovative Business of the Year.
2021
Bedfont® signed an ODM deal to supply Kangdu with it’s NObreath® FeNO device. Shenzhen Century Kangdu Medical Technology Co., Ltd. was established in 2017. The company is located in Pingshan District, Shenzhen, focusing on the R&D, manufacturing and sales of respiratory testing medical devices.
2021
Bedfont® launched its new iCOquit®; a portable, personal Bluetooth® Carbon Monoxide (CO) device to help people quit smoking, which is helping Stop Smoking Services to support their patients remotely during the Coronavirus pandemic.
2021
On 8th December 2021, Kent Med-tech company, Bedfont® Scientific Ltd. celebrated 45 years of business with a 1970’s themed fancy dress party.
2021
In 2021 the Hybrid Working Policy was introduced. This allowed employees to split their time working from home and in the office. Bedfont® recognises the importance of having a good work-life balance.
2019
In 2019, Bedfont® took an executive step to create a Medical Advisory Board for each of its product ranges. The board features Key Opinion Leaders and clinicians who will help Bedfont® to further innovate the devices, whilst offering valuable insight and opportunities into research and clinical studies involving their devices.
2019
In 2019, The Bedfont® Family won its first-ever National business award. The ceremony took place at Wembley Stadium, where Bedfont® were awarded the silver category for Technology and Innovation. This is a double win for Bedfont®, being recognised as a Family business and as a Technology business on a national scale.
2019
The Gastrolyzer® range has been helping to detect gastrointestinal disorders for over 30 years now!
2018
The long-awaited NObreath® was launched in September 2018 at the European Respiratory Congress in Paris. The new NObreath® possesses several new features including SteriTouch® anti-microbial technology, an onscreen flow-meter, and verification of a successful test, and much more.
2018
In 2018, Bedfont® won the South East Exporter of the Year accolade at the Federation of Small Businesses Awards. This was the first regional recognition Bedfont® ever received, which they shared with their 82 distributors, including their very first distributor from Austria.
2018
The NObreath® range celebrated 10 years of aiding in the management and diagnosis of asthma.
2017
After becoming a 2nd generation family business, Bedfont® embraced family values in office and distributor relations. This led to a rebrand in February 2017, changing the NOxBOX® range’s green bubble to purple for NObreath®. The new slogan emerged: “Our family, innovating health, for yours.”
2016
In 2016, Bedfont signed a 3 year ODM deal with LABORIE, a large, international company, to provide an own-branded version of their Gastrolyzer® products. Laborie’s large and successful sales network in Europe and the USA has opened new markets for Bedfont’s products that would take years to access due to the resources required.
2016
The Smokerlyzer®, Gastrolyzer® and ToxCO® ranges had a complete redesign. This included a fresh new look, brand new features, and an easy to use full-colour touchscreen.
2016
The Smokerlyzer® turned 30 years old – that’s 30 years of helping people quit smoking worldwide!
2016
In 2016, Bedfont celebrated 40 years of business, and also became a 2nd generation family business, as Jason became Managing Director, taking over from Trevor, who became Chairman.
2015
NOxBOX® Ltd. is created as a division of Bedfont® and is later sold to Fortune 250 gas company, Praxair Inc, allowing Bedfont® to concentrate on the core business of breath analysis.
2010
Bedfont® moves to its current bespoke offices in Harrietsham, Kent to aid in further expansion.
2008
The NObreath® FeNO device is launched following 5 years of development. The device is used to aid in the diagnosis and management of asthma.
2007
Bedfont® develops a new logo, slogan, and new product range branding.
2000
Bedfont® moves to Rochester, Kent, to be closer to public transport and to allow the company to expand.
1997
The ToxCO® range is established using the knowledge of CO monitoring from the Smokerlyzer® to aid in diagnosis of CO poisoning.
1994
Bedfont® works with Dr Ray Latimer to create a nitric oxide and nitrogen dioxide monitoring system for pulmonary hypertension; the NOxBOX® range is born.
1992
Bedfont® Scientific Ltd. is established and the company becomes 2 divisions; the Bedfont® gasses division and the medical division. Along with the name change came a new logo and slogan.
1991
The Fumigation range is launched with the EC80 phosphine and methyl bromide device to fumigate gas for safety and peace of mind.
1989
Trevor becomes Managing Director. The Smokerlyzer® was found to pick up cross-sensitivity of hydrogen, a gas which can indicate digestive issues, and so the first Gastrolyzer® was developed to monitor hydrogen and help detect gastrointestinal disorders.
1987
Princess Diana demonstrates the Smokerlyzer® as patron of the British Lung Foundation to encourage people to quit smoking.
1985
Trevor Smith joined as Marketing Director in order to expand the gas range and market the world’s first Smokerlyzer® breath carbon monoxide (CO) device, to help people stop smoking. Bedfont® is now based in Upchurch, Kent.
1976
Bedfont Technical Instruments Ltd was established by Dr John Marron. The business was based in London and the first product was the TM3, used to measure piped medical gases. Bedfont® was also a non-refillable gas business.
